Publications by authors named "Grace M Callagy"

Claim this Profile
A
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors.
Lisa A Ridnour, Robert Ys Cheng, Noemi Kedei, Veena Somasundaram, Dibyangana D Bhattacharyya, Grace M Callagy

JCI Insight· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
Elaine M Walsh, Aliaa Shalaby, Mark O'Loughlin, Nessa Keane, Mark J Webber, Grace M Callagy

Breast Cancer Res Treat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.
Grace M Callagy, Mark J Webber, Paul D P Pharoah, Carlos Caldas

BMC Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Grace M Callagy, Paul D Pharoah, Sarah E Pinder, Forrest D Hsu, Torsten O Nielsen

Clin Cancer Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
Huai-En Huang, Suet-Feung Chin, Christophe Ginestier, Valérie-Jeanne Bardou, José Adélaïde, Grace M Callagy

Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis